These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9237412)

  • 41. Neuronal Dysexcitability May Be a Biomarker of Migraine: A Visual Evoked Potential Study.
    Kalita J; Uniyal R; Misra UK; Bhoi SK
    Clin EEG Neurosci; 2018 Sep; 49(5):342-350. PubMed ID: 28974100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intensity dependence of auditory evoked cortical potentials in migraine. Changes in the peri-ictal period.
    Afra J
    Funct Neurol; 2005; 20(4):199-200. PubMed ID: 16483461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visual, long-latency auditory and brainstem auditory evoked potentials in migraine: relation to pattern size, stimulus intensity, sound and light discomfort thresholds and pre-attack state.
    Sand T; Vingen JV
    Cephalalgia; 2000 Nov; 20(9):804-20. PubMed ID: 11167910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood Magnesium levels in migraineurs within and between the headache attacks: a case control study.
    Samaie A; Asghari N; Ghorbani R; Arda J
    Pan Afr Med J; 2012; 11():46. PubMed ID: 22593782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular and plasma magnesium in familial hemiplegic migraine and migraine with and without aura.
    Smeets MC; Vernooy CB; Souverijn JH; Ferrari MD
    Cephalalgia; 1994 Feb; 14(1):29-32. PubMed ID: 8200020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period.
    Kitano A; Shimomura T; Takeshima T; Takahashi K
    Headache; 1994 Oct; 34(9):515-8. PubMed ID: 8002323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multichannel visual evoked potentials in migraine.
    Tagliati M; Sabbadini M; Bernardi G; Silvestrini M
    Electroencephalogr Clin Neurophysiol; 1995 Jan; 96(1):1-5. PubMed ID: 7530184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence of an increased neuronal activation-to-resting glucose uptake ratio in the visual cortex of migraine patients: a study comparing
    Lisicki M; D'Ostilio K; Coppola G; Scholtes F; Maertens de Noordhout A; Parisi V; Schoenen J; Magis D
    J Headache Pain; 2018 Jul; 19(1):49. PubMed ID: 29978429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Event-related potentials (P300) in primary headache in childhood and adolescence.
    Evers S; Bauer B; Grotemeyer KH; Kurlemann G; Husstedt IW
    J Child Neurol; 1998 Jul; 13(7):322-6. PubMed ID: 9701480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of magnesium prophylaxis in migraine without aura.
    Köseoglu E; Talaslioglu A; Gönül AS; Kula M
    Magnes Res; 2008 Jun; 21(2):101-8. PubMed ID: 18705538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visual evoked potential latency, amplitude and habituation in migraine: a longitudinal study.
    Sand T; Zhitniy N; White LR; Stovner LJ
    Clin Neurophysiol; 2008 May; 119(5):1020-7. PubMed ID: 18308628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pattern-reversal visual evoked potentials in migraineurs with or without visual aura.
    Sener HO; Haktanir I; Demirci S
    Headache; 1997; 37(7):449-51. PubMed ID: 9277029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum levels of N-acetyl-aspartate in migraine and tension-type headache.
    de Tommaso M; Ceci E; Pica C; Trojano M; Delussi M; Franco G; Livrea P; Ruggieri M
    J Headache Pain; 2012 Jul; 13(5):389-94. PubMed ID: 22527035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The movement-related potential in children with migraine and tension-type headache.
    Müller BW; Sartory G; Tackenberg A
    Cephalalgia; 2002 Mar; 22(2):125-31. PubMed ID: 11972580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Proinflammatory cytokines in children with idiopathic headache].
    Gergont A; Kaciński M; Kwinta P
    Przegl Lek; 2005; 62(11):1269-75. PubMed ID: 16512619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous recording of pattern reversal electroretinograms and visual evoked potentials in migraine.
    Shibata K; Osawa M; Iwata M
    Cephalalgia; 1997 Nov; 17(7):742-7. PubMed ID: 9399003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pattern reversal visual evoked potentials (VEP-PR) in migraine subjects with visual aura.
    Mariani E; Moschini V; Pastorino GC; Rizzi F; Severgnini A; Tiengo M
    Headache; 1990 Jun; 30(7):435-8. PubMed ID: 2401626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Asymmetric scalp distribution of pattern visual evoked potentials during interictal phases in migraine.
    Logi F; Bonfiglio L; Orlandi G; Bonanni E; Iudice A; Sartucci F
    Acta Neurol Scand; 2001 Nov; 104(5):301-7. PubMed ID: 11696025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there a role of clinical neurophysiology in primary headache?
    Valeriani M
    Clin Neurophysiol; 2005 Dec; 116(12):2717-8. PubMed ID: 16253549
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluating the effects of spatial frequency on migraines by using pattern-reversal visual evoked potentials.
    Shibata K; Yamane K; Iwata M; Ohkawa S
    Clin Neurophysiol; 2005 Sep; 116(9):2220-7. PubMed ID: 16043404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.